Humana Inc. (HUM) Q4 2022 Earnings Call Transcript
Humana Inc. (NYSE:HUM) Q4 2022 Earnings Conference Call February 1, 2023 9:00 AM ET
Company Participants
Lisa Stoner – Vice President-Investor Relations
Bruce Broussard – President and Chief Executive Officer
Susan Diamond – Chief Financial Officer
Conference Call Participants
Josh Raskin – Nephron Research
A.J. Rice – Credit Suisse
Justin Lake – Wolfe Research
Kevin Fischbeck – Bank of America
Stephen Baxter – Wells Fargo
Scott Fidel – Stephens
Gary Taylor – Cowen
Nathan Rich – Goldman Sachs
Lisa Gill – JPMorgan
Michael Ha – Morgan Stanley
Steven Valiquette – Barclays
George Hill – Deutsche Bank
Ben Hendrix – RBC
Operator
Good day and thank you for standing by. Welcome to the Humana Fourth Quarter Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Lisa Stoner, VP of Investor Relations. Please go ahead.
Lisa Stoner
Thank you, and good morning. In a moment, Bruce Broussard, Humana’s President and Chief Executive Officer; and Susan Diamond, Chief Financial Officer, will discuss our fourth quarter 2022 results and our initial financial outlook for 2023. Following these prepared remarks, we will open up the lines for a question-and-answer session with industry analysts. Joe Ventura, our Chief Legal Officer, will also be joining Bruce and Susan for the Q&A session. We encourage the investing public and media to listen to both management’s prepared remarks and the related Q&A with analysts. This call is being recorded for replay purposes. That replay will be available on the Investor Relations page of Humana’s website, humana.com, later today.
Before we begin our discussion, I need to advise call participants of our cautionary statement. Certain of the matters discussed in this conference call are forward-looking and involve a number of risks and uncertainties. Actual results could differ materially. Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other filings with the Securities and Exchange Commission and our fourth quarter 2022 earnings press release as they relate to forward-looking statements along with other risks discussed in our SEC filings. We undertake no obligation to publicly address or update any forward-looking statements and future filings or communications regarding our business or results. Today’s press release, our historical financial news releases and our filings with the SEC are all also available on our Investor Relations site.